Companies / Bicara Therapeutics Inc. / Activity
Activity — Bicara Therapeutics Inc.
67 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $4.80M | +300K +6.97% | 4,603,418 6.96% of shares | high |
| Mar 9, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $704.7K | -37K -9.77% | 339,392 0.51% of shares | medium |
| Mar 4, 2026 | Raben David Executive | Sell | Common Stock | $301.9K | -16K -22.77% | 55,286 0.08% of shares | medium |
| Mar 3, 2026 | Hyep Ivan Executive | Sell | Common Stock | $246.9K | -14K -8.53% | 145,355 0.22% of shares | medium |
| Mar 3, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $234.2K | -13K -5.79% | 209,641 0.32% of shares | medium |
| Mar 23, 2026 | Hyep Ivan Executive | Sell | Common Stock | $170.3K | -9K -5.95% | 145,355 0.22% of shares | medium |
| Mar 16, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $157.3K | -8K -3.75% | 205,141 0.31% of shares | medium |
| Mar 9, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $139.3K | +37K +10.83% | 376,158 0.57% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $129.7K | -7K -1.99% | 339,392 0.51% of shares | medium |
| Mar 18, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $122.4K | -6K -1.88% | 339,392 0.51% of shares | medium |
| Mar 25, 2026 | Raben David Executive | Sell | Common Stock | $104.2K | -6K -9.05% | 55,286 0.08% of shares | medium |
| Mar 16, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $88.5K | -5K -2.19% | 200,641 0.30% of shares | low |
| Mar 3, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $81.7K | -5K -2.15% | 205,141 0.31% of shares | low |
| Mar 6, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $71.6K | -4K -1.11% | 339,392 0.51% of shares | low |
| Jan 22, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $69.3K | -4K -1.79% | 210,164 0.32% of shares | low |
| Mar 4, 2026 | Raben David Executive | Exercise | Common Stock | $61.8K | +16K +29.48% | 71,586 0.11% of shares | low |
| Feb 25, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $56.1K | -3K -1.46% | 210,164 0.32% of shares | low |
| Mar 4, 2026 | Hyep Ivan Executive | Sell | Common Stock | $54.1K | -3K -2.00% | 145,355 0.22% of shares | low |
| Mar 4, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $49.3K | -3K -0.77% | 339,392 0.51% of shares | low |
| Mar 3, 2026 | Cohlhepp Ryan Executive | Exercise | Common Stock | $48.9K | +13K +6.15% | 222,533 0.34% of shares | low |
| Mar 23, 2026 | Hyep Ivan Executive | Exercise | Common Stock | $34.9K | +9K +6.33% | 154,555 0.23% of shares | low |
| Jan 22, 2026 | Hyep Ivan Executive | Sell | Common Stock | $34.2K | -2K -1.28% | 145,355 0.22% of shares | low |
| Mar 5, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $33.5K | -2K -0.52% | 339,392 0.51% of shares | low |
| Mar 16, 2026 | Cohlhepp Ryan Executive | Exercise | Common Stock | $30.3K | +8K +3.90% | 213,141 0.32% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $30.2K | -2K -0.47% | 339,392 0.51% of shares | low |
| Mar 3, 2026 | Hyep Ivan Executive | Exercise | Common Stock | $27.7K | +7K +5.03% | 152,673 0.23% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $26.2K | +7K +2.03% | 346,297 0.52% of shares | low |
| Mar 18, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $24.6K | +6K +1.91% | 345,891 0.52% of shares | low |
| Mar 3, 2026 | Hyep Ivan Executive | Exercise | Common Stock | $23.6K | +6K +4.09% | 158,910 0.24% of shares | low |
| Mar 25, 2026 | Raben David Executive | Exercise | Common Stock | $20.8K | +6K +9.95% | 60,786 0.09% of shares | low |
| Mar 6, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $14.5K | +4K +1.12% | 343,209 0.52% of shares | low |
| Feb 25, 2026 | Cohlhepp Ryan Executive | Exercise | Common Stock | $11.8K | +3K +1.48% | 213,272 0.32% of shares | low |
| Mar 4, 2026 | Hyep Ivan Executive | Exercise | Common Stock | $11.2K | +3K +2.04% | 148,318 0.22% of shares | low |
| Mar 4, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $10.0K | +3K +0.78% | 342,023 0.52% of shares | low |
| Feb 25, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $9.4K | -523 -0.25% | 209,641 0.32% of shares | low |
| Jan 22, 2026 | Hyep Ivan Executive | Exercise | Common Stock | $7.1K | +2K +1.29% | 147,237 0.22% of shares | low |
| Mar 5, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $6.8K | +2K +0.53% | 341,178 0.52% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $6.0K | +2K +0.47% | 340,988 0.52% of shares | low |
| Mar 3, 2026 | Raben David Executive | Sell | Common Stock | $3.7K | -200 -0.36% | 55,286 0.08% of shares | low |
| Jan 15, 2026 | Cohlhepp Ryan Executive | Sell | Common Stock | $2.7K | -149 -0.07% | 213,992 0.32% of shares | low |
| Mar 3, 2026 | Raben David Executive | Exercise | Common Stock | $758 | +200 +0.36% | 55,486 0.08% of shares | low |
| Jun 9, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +19K | 19,475 0.03% of shares | low |
| Jun 9, 2026 | Powell Michael Director | Grant | Stock Option (Right to Buy) | — | +19K | 19,475 0.03% of shares | low |
| Mar 25, 2026 | Raben David Executive | Exercise | Stock Option (Right to Buy) | — | -6K -10.39% | 47,413 0.07% of shares | low |
| Mar 23, 2026 | Hyep Ivan Executive | Exercise | Stock Option (Right to Buy) | — | -9K -15.82% | 48,944 0.07% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -2K -0.90% | 176,107 0.27% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -7K -3.74% | 177,703 0.27% of shares | low |
| Mar 18, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -6K -3.40% | 184,608 0.28% of shares | low |
| Mar 16, 2026 | Cohlhepp Ryan Executive | Exercise | Stock Option (Right to Buy) | — | -8K -6.38% | 117,334 0.18% of shares | low |
| Mar 9, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -37K -16.13% | 191,107 0.29% of shares | low |